Tolerance and pharmacokinetics of a ciprofloxacin‐coated sinus stent in a preclinical model

Abstract

The CSS was safe in this preclinical model and sustained release was observed in both the in vitro and in vivo analyses. The innovative stent design coated with ciprofloxacin may provide a unique therapeutic strategy for chronic rhinosinusitis (CRS).